Quanterix QTRX
NASDAQ QTRX
$3.12 +0.16 (+5.42%)
As of: Aug 20, 2026 · 3:59 PM EDT

Quanterix (QTRX) Liabilities and Shareholders Equity (2017 - 2026)

Quanterix's (QTRX) quarterly Liabilities and Shareholders Equity came in at $366.7 million in Q1 2026, down 7.53% YoY from $396.5 million in Q1 2025, and down 12.44% on a QoQ basis from $418.8 million in Q4 2025.

Quanterix (QTRX) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Quanterix (QTRX) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $366.7 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 7.53% year-over-year to $366.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (down 1.52% YoY) and the FY2025 annual result came in at $418.8 million, up 3.01% from the prior year.
  • Liabilities and Shareholders Equity retreated to $366.7 million in Q1 2026, from $418.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $506.7 million in Q1 2022 to a low of $366.7 million in Q1 2026.
  • A 5-year average of $425.6 million and a median of $425.7 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity declined 15.98% — and 2025, when it climbed 8.06%.
  • Tracing QTRX's Liabilities and Shareholders Equity over 5 years: stood at $433.6 million in 2022, then declined by 1.16% to $428.6 million in 2023, then retreated by 5.14% to $406.5 million in 2024, then grew by 3.01% to $418.8 million in 2025, then retreated by 12.44% to $366.7 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $366.7 million (Q1 2026), $418.8 million (Q4 2025), and $444.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 Quanterix 146.22 Mn 52.69 Mn 12.67 Mn 319.63 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 319.63 Mn
Mar 31, 2026 366.67 Mn
Dec 31, 2025 418.77 Mn
Sep 30, 2025 444.14 Mn
Jun 30, 2025 375.61 Mn
Mar 31, 2025 396.51 Mn
Dec 31, 2024 406.53 Mn
Sep 30, 2024 411.03 Mn
Jun 30, 2024 415.92 Mn
Mar 31, 2024 414.21 Mn
Dec 31, 2023 428.57 Mn
Sep 30, 2023 429.22 Mn
Jun 30, 2023 428.27 Mn
Mar 31, 2023 425.72 Mn
Dec 31, 2022 433.58 Mn
Sep 30, 2022 445.57 Mn
Jun 30, 2022 488.68 Mn
Mar 31, 2022 506.69 Mn
Dec 31, 2021 501.53 Mn
Sep 30, 2021 510.84 Mn